October 17, 2024
TOPLINE: Induction chemotherapy followed by chemoradiotherapy improves 5-year overall survival rates in advanced cervical cancer from 72% to 80%. The treatment also enhances 5-year progression-free survival […]
October 17, 2024
Premenstrual disorders (PMDs), including premenstrual dysphoric disorder (PMDD), adversely affect the lives of millions of women worldwide. Most girls and women — as many as 80%-90%— […]
October 17, 2024
Share on PinterestBurger King’s free 8oz “Big Dip” tubs of ranch dressing can significantly increase the number of calories, fat, and sodium you consume with a […]
October 16, 2024
Summary Company Announcement Date: October 08, 2024 FDA Publish Date: October 16, 2024 Product Type: Drugs Reason for Announcement: Recall Reason Description Device & Drug Safety […]
October 16, 2024
Summary Company Announcement Date: October 10, 2024 FDA Publish Date: October 16, 2024 Product Type: Drugs Reason for Announcement: Recall Reason Description Device & Drug Safety […]
October 16, 2024
TOPLINE: Five-fraction stereotactic body radiotherapy (SBRT) was found to be noninferior to conventionally or moderately hypofractionated radiotherapy in treating localized prostate cancer, with a 5-year freedom […]
October 16, 2024
SAVANNAH, GEORGIA – The investigational monoclonal antibody nipocalimab (Johnson & Johnson) is associated with significant improvement in patients with generalized myasthenia gravis (gMG) over a 24-week […]
October 16, 2024
HOW TO USE THIS SNAPSHOTThe information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this drug, […]
October 16, 2024
HOW TO USE THIS SNAPSHOTThe information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this drug, […]